INFORCE 3 New Approval
INFORCE 3, the top selling cattle vaccine on the market, has earned a single nostril administration claim to make it more convenient to administer.
Studies demonstrated that when the full 2-mL dose was administered into a single nostril in neonatal calves, INFORCE 3 protected against respiratory disease caused by infectious bovine rhinotracheitis (IBR) virus, bovine respiratory syncytial virus (BRSV) and parainfluenza 3 (PI3) virus.
In additional studies, INFORCE 3 also demonstrated the ability to override maternal antibodies to moderate IBR respiratory disease for at least 15 weeks and provided IBR respiratory protection for more than six months in IBR-naïve neonatal calves.
The vaccine contains proprietary temperature-sensitive IBR and PI3 viral strains, as well as naturally temperature-sensitive BRSV. This formulation stimulates protective immunity in the nasal passages, while also priming the immune system for a rapid memory response to subsequent vaccination or disease challenge. INFORCE 3 is safe for use in all calves.